Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing
Biolevate has raised €6.0M across 1 funding round from 1 investor, most recently a Seed round in Nov 2024. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-11-26 | Seed | €6.0M |
| EQT Ventures |
| View deal → |
